- Acid reflux
- Heartburn
- GERD
- Acid-related dyspepsia
- Gastrointestinal motility-related symptoms
RABVIV-LS CAP combines rabeprazole with levosulpiride to provide acid suppression and gastrointestinal motility support. It is intended for selected acid-related and functional gastrointestinal conditions.
Used in appropriate patients with acid-related gastrointestinal disorders requiring acid suppression and prokinetic therapy.
Take orally as prescribed, generally before meals. Swallow the capsule whole with water.
Headache, nausea, abdominal discomfort, diarrhoea, constipation or dizziness may occur.
Store in a cool, dry place away from direct sunlight and moisture.
Product information is provided for professional and informational purposes. Please refer to the approved product labeling and applicable professional guidance for appropriate use.